Ghent University Academic Bibliography

Advanced

Caniene cutane mastceltumoren

Lynn Van Eetvelde, Koen Chiers UGent and Leen Van Brantegem UGent (2017) VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT. 86(5). p.311-321
abstract
Canine cutaneous mast cell tumors (cMCT) are a commonly encountered neoplasia in small animal practice. Ninety-six percent of the cMCT can be diagnosed with cytology. Because of the variating biological character, it's difficult to establish a prognosis. Therefore, the prognosis is assessed with multiple prognostic factors: tumor location, systemic complaints, metastases, histological and cytological grading, proliferation markers, KIT-staining pattern, KIT-mutation and tumor free margins. The treatment of choice is based upon the results of these prognostic factors, the clinical stage and the tumor location. Possible treatments include surgery, radiotherapy, chemotherapy, electrochemotherapy, tyrosine kinase inhibitors, cryotherapy and intraregional therapy with deionized water.
Please use this url to cite or link to this publication:
author
organization
alternative title
Canine cutaneous mast cell tumors
year
type
journalArticle (original)
publication status
published
subject
keyword
PROGNOSTIC-FACTORS, SURGICAL EXCISION, DOUBLE-BLIND, DOGS, SURVIVAL, THERAPY, MASTOCYTOSIS, PREDNISONE, EXPRESSION, BEHAVIOR
journal title
VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT
Vlaams Diergeneesk. Tijdschr.
volume
86
issue
5
pages
311 - 321
Web of Science type
Article
Web of Science id
000414775500006
ISSN
0303-9021
language
Dutch
UGent publication?
yes
classification
A1
copyright statement
I have retained and own the full copyright for this publication
id
8549390
handle
http://hdl.handle.net/1854/LU-8549390
date created
2018-02-12 08:00:30
date last changed
2018-03-14 13:19:36
@article{8549390,
  abstract     = {Canine cutaneous mast cell tumors (cMCT) are a commonly encountered neoplasia in small animal practice. Ninety-six percent of the cMCT can be diagnosed with cytology. Because of the variating biological character, it's difficult to establish a prognosis. Therefore, the prognosis is assessed with multiple prognostic factors: tumor location, systemic complaints, metastases, histological and cytological grading, proliferation markers, KIT-staining pattern, KIT-mutation and tumor free margins. The treatment of choice is based upon the results of these prognostic factors, the clinical stage and the tumor location. Possible treatments include surgery, radiotherapy, chemotherapy, electrochemotherapy, tyrosine kinase inhibitors, cryotherapy and intraregional therapy with deionized water.},
  author       = {Van Eetvelde, Lynn and Chiers, Koen and Van Brantegem, Leen},
  issn         = {0303-9021},
  journal      = {VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT},
  keyword      = {PROGNOSTIC-FACTORS,SURGICAL EXCISION,DOUBLE-BLIND,DOGS,SURVIVAL,THERAPY,MASTOCYTOSIS,PREDNISONE,EXPRESSION,BEHAVIOR},
  language     = {dut},
  number       = {5},
  pages        = {311--321},
  title        = {Caniene cutane mastceltumoren},
  volume       = {86},
  year         = {2017},
}

Chicago
Van Eetvelde, Lynn, Koen Chiers, and Leen Van Brantegem. 2017. “Caniene Cutane Mastceltumoren.” Vlaams Diergeneeskundig Tijdschrift 86 (5): 311–321.
APA
Van Eetvelde, L., Chiers, K., & Van Brantegem, L. (2017). Caniene cutane mastceltumoren. VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT, 86(5), 311–321.
Vancouver
1.
Van Eetvelde L, Chiers K, Van Brantegem L. Caniene cutane mastceltumoren. VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT. 2017;86(5):311–21.
MLA
Van Eetvelde, Lynn, Koen Chiers, and Leen Van Brantegem. “Caniene Cutane Mastceltumoren.” VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT 86.5 (2017): 311–321. Print.